Basilea Pharmaceutica AG

Fr 71.00As of Sun 8 Nov 2026, 12:00 UTC
SWX:BSLNHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR 0.63%
Div yield —
ROE 39.46%
Biotechnology
Beta (5Y) 0.32
PE TTM 17.71
TSR TTM 52.69%
Mkt cap Fr 882.3M
ROIC 73.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 91
28.59%
(50.45%)
Hold 3|1|9|6|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
1.11
1.22
1.21
1.16
15.65%
13.10%
14.41%
13.04%
RevenueFr M
46.71
47.74
47.50
46.82
11.52%
11.57%
9.59%
5.97%
Peers (US$1.082B)
Cap (US$)
PE
2.414B
—
1.343B
—
Capital
TTM
5Y
10Y
Leveragex
0.659
1.261
1.153
EBIT/Intx
0.500
0.446
0.380
Own earn%
85.78
(11.74)
(20.82)
Sh yield%
37.94
52.00
49.05
Owners
Insiders/Inst%
7.85
74.12
Short interest%
5.25
SBC / revenue%
2.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
6–12
$1 testx
1.9
Incr. ROIC%
2